Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

HNX:PMC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	32,564	40,564	60,084	13,252	37,454	29,430
Short-Term Investments	500	500	141,000	249,000	256,100	242,131
Cash & Short-Term Investments	33,064	41,064	201,084	262,252	293,554	271,560
Cash Growth	-65.91%	-79.58%	-23.32%	-10.66%	8.10%	19.88%
Accounts Receivable	50,718	33,666	41,222	39,310	35,254	39,175
Other Receivables	2,196	781.3	3,042	3,605	3,233	2,159
Receivables	52,914	34,448	44,264	42,915	38,487	41,335
Inventory	146,968	103,930	71,119	67,244	104,546	71,379
Prepaid Expenses	-	3,564	435.06	453.29	282.38	915.04
Other Current Assets	39,472	36,570	18,533	6,207	4,273	3,853
Total Current Assets	272,417	219,576	335,436	379,071	441,141	389,042
Property, Plant & Equipment	100,831	93,635	32,127	39,704	45,890	53,900
Other Intangible Assets	15,120	1,998	2,214	2,443	2,731	2,991
Other Long-Term Assets	-	30,216	6,062	5,157	4,362	5,560
Total Assets	413,010	345,424	375,839	426,375	494,124	451,494

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	27,575	28,535	16,250	12,730	15,668	8,378
Accrued Expenses	24,445	45,726	44,572	46,302	36,141	38,986
Short-Term Debt	86,867	181.01	-	-	-	-
Current Income Taxes Payable	4,151	7,560	6,580	7,821	7,364	7,203
Current Unearned Revenue	1,682	1,941	1,457	1,002	669.46	804.02
Other Current Liabilities	15,800	20,626	17,369	15,322	6,500	7,246
Total Current Liabilities	160,519	104,569	86,227	83,178	66,342	62,617
Total Liabilities	160,519	104,569	86,227	83,178	66,342	62,617

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	93,326	93,326	93,326	93,326	93,326	93,326
Additional Paid-In Capital	972.97	972.97	972.97	972.97	972.97	972.97
Retained Earnings	158,192	146,557	195,313	248,898	333,483	294,578
Total Common Equity	252,490	240,855	289,612	343,197	427,782	388,877
Shareholders' Equity	252,490	240,855	289,612	343,197	427,782	388,877
Total Liabilities & Equity	413,010	345,424	375,839	426,375	494,124	451,494

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	86,867	181.01	-	-	-	-
Net Cash (Debt)	-53,803	40,883	201,084	262,252	293,554	271,560
Net Cash Growth	-	-79.67%	-23.32%	-10.66%	8.10%	19.88%
Net Cash Per Share	-5765.07	4380.69	21546.50	28100.75	31454.72	29098.14
Filing Date Shares Outstanding	9.33	9.33	9.33	9.33	9.33	9.33
Total Common Shares Outstanding	9.33	9.33	9.33	9.33	9.33	9.33
Working Capital	111,898	115,007	249,208	295,893	374,799	326,425
Book Value Per Share	27054.73	25808.03	31032.37	36774.09	45837.52	41668.77
Tangible Book Value	237,371	238,858	287,397	340,754	425,052	385,886
Tangible Book Value Per Share	25434.65	25593.97	30795.08	36512.36	45544.94	41348.27
Buildings	33,322	33,322	32,966	32,966	32,966	32,966
Machinery	274,659	255,859	190,875	187,316	182,470	181,032
Construction In Progress	176.71	2,418	68.69	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error